Oncology

TUBE Pharmaceuticals is a biotechnology company with a focus on potent natural product derived small molecules suitable for drug conjugation.
Together with advanced targeting approaches, we expect to deliver safer and more effective therapies preventing tumor resistance.
Our pipeline includes the proprietary toxin classes Tubulysins/Cytolysins conjugated to different targeting molecules, eg. ADCs, PDCs., the proprietary, next generation Epothilones and an inlicensed peptide (Argyrin).

Schlagworte

Website

https://www.tubepharma.at